A SYNTHETIC APPROACH TOWARDS NOVEL SERIES OF 3-(3-(1-PIPERAZINYL)PROPYL -1H-INDOLE DERIVATIVES AS MONOAMINERGIC MULTI-TARGET AGENTS. DOCKING STUDIES AND PHARMACOLOGICAL EVALUATION AT SERT, D2, AND MAO-A RECEPTORS.